Header for print stylesheet
You are here:  
Redivivo® Lycopene from DSM Nutritional Products is now approved in the EU
Kaiseraugst,CH,13 Mar 2009

DSM Nutritional Products is pleased to confirm that redivivo® Lycopene has been cleared for marketing in the EU following approval by the European Commission Standing Committee on the Food Chain and Animal Health (SCFCAH).

After intensive work by DSM scientists and regulatory experts, and a positive safety assessment by the European Food Safety Authority, approval was granted at the SCFCAH meeting held on 20th February 2009. Formal publication of the decision in the European Official Journal is expected shortly.

Redivivo® has been affirmed ‘Generally Recognized As Safe (GRAS/SA)’ in the U.S. in 2002, and is, besides North America, already successfully marketed in most countries of Asia, Latin America and Eastern Europe. Now redivivo® Lycopene can be introduced in the EU-Countries as well.

Lycopene is known as strong antioxidant. It helps to protect the body from free radicals, which can cause damage to cells and may play a role in the onset of a number of diseases. Epidemiological studies indicate association between a lycopene-rich diet and reduced risk for cardiovascular diseases and prostate cancer.

Lycopene cannot be synthesized by humans and must be consumed from the diet.
Redivivo® from DSM Nutritional Products is available in several product formulations making it an excellent source for food, beverage and dietary supplement applications.

About DSM Nutritional Products
DSM Nutritional Products is the world's leading supplier of vitamins, carotenoids and other fine chemicals to the feed, food, pharmaceutical and personal care industries. The business has sales of over EUR 2 billion and a long tradition as a pioneer in the discovery of new products, new formulations and attractive applications for all industry segments. For further company information please visit www.dsmnutritionalproducts.com.

DSM – the Life Sciences and Materials Sciences Company
Royal DSM N.V. creates innovative products and services in Life Sciences and Materials Sciences that contribute to the quality of life. DSM’s products and services are used globally in a wide range of markets and applications, supporting a healthier, more sustainable and more enjoyable way of life. End markets include human and animal nutrition and health, personal care, pharmaceuticals, automotive, coatings and paint, electrical and electronics, life protection and housing. DSM has annual net sales of EUR 9.3 billion and employs some 23,500 people worldwide. The company is headquartered in the Netherlands, with locations on five continents. DSM is listed on Euronext Amsterdam. More information: www.dsm.com.

 

For more information:
DSM Nutritional Products
Charlotte Frederiksen
Tel. +41 (0)61 815 83 54
Fax +41 (0)61 815 88 90
E-mail: charlotte.frederiksen@dsm.com

 

  

Forward-looking statements
This press release contains forward-looking statements. These statements are based on current expectations, estimates and projections of DSM and information currently available to the company. The statements involve certain risks and uncertainties that are difficult to predict and therefore DSM does not guarantee that its expectations will be realized. Furthermore, DSM has no obligation to update the statements contained in this press release. The English language version of the press release is leading.

For more information:
DSM Nutritional Products Charlotte Frederiksen
Tel. :+41 (0) 61 815 8354 Fax:+41 (0) 61 815 8890
charlotte.frederiksen@dsm.com
footer for print stylesheet